June 18 (Reuters) - Autonomix Medical Inc AMIX.O :
* AUTONOMIX ANNOUNCES POSITIVE TOPLINE RESULTS FROM FIRST
FIVE
LEAD-IN PATIENTS IN ONGOING HUMAN CLINICAL TRIAL
* AUTONOMIX MEDICAL INC: TRIAL REMAINS ON TRACK TO COMPLETE
ENROLLMENT BY YEAR-END 2024
* AUTONOMIX MEDICAL: 60% OF STUDY SUBJECTS RESPONDED WITH
MEAN
6.33 REDUCTION OF PAIN ON VAS PAIN SCALE AT 7 DAYS
POST-PROCEDURE
* AUTONOMIX MEDICAL: RESPONDER PATIENTS REPORTED MEAN 78%
IMPROVEMENT IN QUALITY OF HEALTH AT 7 DAYS POST-PROCEDURE
* AUTONOMIX MEDICAL INC: RESPONDER PATIENTS REPORTED MEAN
45%
IMPROVEMENT IN QUALITY OF LIFE AT 7 DAYS POST-PROCEDURE
Source text for Eikon: ID:nGNX9GJqry
Further company coverage: AMIX.O
((Reuters.Briefs@thomsonreuters.com;))